Advantage of a baculovirus expression system for protein-protein interaction studies. Involvement of posttranslational phosphorylation in the interaction between wt p53 protein and poly(ADP-ribose) polymerase-1

Acta Biochimica Polonica

Volumn 52, Issue 3, 2005, Pages 713-719

  Schmid, Gerald ^a,b   Wojciechowski, Jacek ^a   Wȩsierska Ga̧dek, Józefa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

2D PAGE; Cell cycle arrest; FACS analysis; NES; Nucleocytoplasmic shuttling; p53 isomers; p53 nuclear export; p53 phosphorylation; p53 pull down assay; p53 stability

Indexed keywords

INSECTA; MAMMALIA;

EID: 27644578806     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2005_3435     Document Type: Conference Paper

References (27)

1. Apella E, Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772.
2. Bargonetti J, Manfredi JJ (2002) Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14: 86-91.
3. Berger NA (1985) Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 101: 4-15.
4. Blagosklonny MV (2002) P53: An ubiquitous target of anticancer drugs. Int J Cancer 98: 161-166.
5. D'Amours D, Desnoyers S, D'Silvia I, Poirier GG (1999) Poly(ADP-ribosyl)ation reactions in the regulations of nuclear functions. Biochem J 342: 249-268.
6. de Murcia G, Menissier-de Murcia J (1994) Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 19: 172-176.
7. Donehower LA (2002) Does p53 affect organismal aging? J Cell Physiol 192: 23-33.
8. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
9. Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN, Ronai Z (1998) JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 12: 2658-2663.
10. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
11. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303.
12. 4. Nature 227: 680-685.
13. Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, Sutherland A, Thorner M, Scrable H (2004) Modulation of mammalian life span by a short isoform of p53. Genes Dev 18: 306-319.
14. Momand J, Zambetti G, Olson D, George D, Levine AJ (1992) The Mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
15. Mowat MR (1998) p53 in tumor progression: life, death, and everything. Adv Cancer Res 74: 25-48.
16. O'Farell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021.
17. O'Reilly DR, Miller LK, Luckow VA (1994) Baculovirus Expression Vectors: A Laboratory Manual. Freeman, New York.
18. Shaulsky G, Ben-Ze'ev A, Rotter V (1990) Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5: 1707-1711.
19. Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18: 1660-1672.
20. 1 checkpoint. J Cell Biochem 80: 85-103.
21. Wesierska-Gadek J, Schmid G (2001) Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. Cell Mol Biol Lett 6: 117-140.
22. Wesierska-Gadek J, Bugajska-Schretter A, Cerni C (1996a) ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified. J Cell Biochem 62: 90-101.
23. Wesierska-Gadek J, Schmid G, Cerni C (1996b) ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. Biochem Biophys Res Commun 224: 96-102.
24. Wesierska-Gadek J, Wang ZQ, Schmid G (1999) Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts. Cancer Res 59: 28-34.
25. Wesierska-Gadek J, Bohrn E, Herceg Z, Wang Z-Q, Wurzer G (2000) Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors. J Cell Biochem 78: 681-696.
26. Wesierska-Gadek J, Wojciechowski J, Schmid G (2003a) Central and carboxy-terminal regions of human p53 protein are essential for interaction and complex formation with PARP-1. J Cell Biochem 89: 220-232.
27. Wesierska-Gadek J, Wojciechowski J, Schmid G (2003b) Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1. J Cell Biochem 89: 1260-1284.